193 related articles for article (PubMed ID: 11912060)
21. Polynucleotide phosphorylase and mitochondrial ATP synthase mediate reduction of arsenate to the more toxic arsenite by forming arsenylated analogues of ADP and ATP.
Németi B; Regonesi ME; Tortora P; Gregus Z
Toxicol Sci; 2010 Oct; 117(2):270-81. PubMed ID: 20457661
[TBL] [Abstract][Full Text] [Related]
22. Trivalent arsenicals are bound to proteins during reductive methylation.
Naranmandura H; Suzuki N; Suzuki KT
Chem Res Toxicol; 2006 Aug; 19(8):1010-8. PubMed ID: 16918239
[TBL] [Abstract][Full Text] [Related]
23. Biliary excretion of [(GS)(2)AsSe](-) after intravenous injection of rabbits with arsenite and selenate.
Gailer J; George GN; Pickering IJ; Prince RC; Younis HS; Winzerling JJ
Chem Res Toxicol; 2002 Nov; 15(11):1466-71. PubMed ID: 12437338
[TBL] [Abstract][Full Text] [Related]
24. Intracellular interaction and metabolic fate of arsenite and arsenate in mice and rabbits.
Vahter M; Marafante E
Chem Biol Interact; 1983 Oct; 47(1):29-44. PubMed ID: 6640784
[TBL] [Abstract][Full Text] [Related]
25. Accumulation and metabolism of arsenic in mice after repeated oral administration of arsenate.
Hughes MF; Kenyon EM; Edwards BC; Mitchell CT; Razo LM; Thomas DJ
Toxicol Appl Pharmacol; 2003 Sep; 191(3):202-10. PubMed ID: 13678653
[TBL] [Abstract][Full Text] [Related]
26. Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.
Wang Z; Zhou J; Lu X; Gong Z; Le XC
Chem Res Toxicol; 2004 Jan; 17(1):95-103. PubMed ID: 14727923
[TBL] [Abstract][Full Text] [Related]
27. Generation of thioarsenicals is dependent on the enterohepatic circulation in rats.
Bu N; Wang HY; Hao WH; Liu X; Xu S; Wu B; Anan Y; Ogra Y; Lou YJ; Naranmandura H
Metallomics; 2011 Oct; 3(10):1064-73. PubMed ID: 21779592
[TBL] [Abstract][Full Text] [Related]
28. Bacterial ability in AsIII oxidation and AsV reduction: Relation to arsenic tolerance, P uptake, and siderophore production.
Ghosh P; Rathinasabapathi B; Teplitski M; Ma LQ
Chemosphere; 2015 Nov; 138():995-1000. PubMed ID: 25576133
[TBL] [Abstract][Full Text] [Related]
29. Arsenic speciation in saliva of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.
Chen B; Cao F; Yuan C; Lu X; Shen S; Zhou J; Le XC
Anal Bioanal Chem; 2013 Feb; 405(6):1903-11. PubMed ID: 23318765
[TBL] [Abstract][Full Text] [Related]
30. Automated, continuous, and dynamic speciation of urinary arsenic in the bladder of living organisms using microdialysis sampling coupled on-line with high performance liquid chromatography and hydride generation atomic absorption spectrometry.
Tseng WC; Yang MH; Chen TP; Huang YL
Analyst; 2002 Apr; 127(4):560-4. PubMed ID: 12022658
[TBL] [Abstract][Full Text] [Related]
31. High As exposure induced substantial arsenite efflux in As-hyperaccumulator Pteris vittata.
Chen Y; Fu JW; Han YH; Rathinasabapathi B; Ma LQ
Chemosphere; 2016 Feb; 144():2189-94. PubMed ID: 26595313
[TBL] [Abstract][Full Text] [Related]
32. Enzymatic methylation of arsenic compounds: IV. In vitro and in vivo deficiency of the methylation of arsenite and monomethylarsonic acid in the guinea pig.
Healy SM; Zakharyan RA; Aposhian HV
Mutat Res; 1997 Jun; 386(3):229-39. PubMed ID: 9219561
[TBL] [Abstract][Full Text] [Related]
33. Arsenic speciation in rice samples for trace level determination by high performance liquid chromatography-inductively coupled plasma-mass spectrometry.
Kara S; Chormey DS; Saygılar A; Bakırdere S
Food Chem; 2021 Sep; 356():129706. PubMed ID: 33831825
[TBL] [Abstract][Full Text] [Related]
34. Distributions and chemical forms of arsenic after intravenous administration of dimethylarsinic and monomethylarsonic acids to rats.
Suzuki KT; Katagiri A; Sakuma Y; Ogra Y; Ohmichi M
Toxicol Appl Pharmacol; 2004 Aug; 198(3):336-44. PubMed ID: 15276413
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxicity of combinations of arsenicals on rat urinary bladder urothelial cells in vitro.
Nascimento MG; Suzuki S; Wei M; Tiwari A; Arnold LL; Lu X; Le XC; Cohen SM
Toxicology; 2008 Jul; 249(1):69-74. PubMed ID: 18502017
[TBL] [Abstract][Full Text] [Related]
36. Development of a human physiologically based pharmacokinetic (PBPK) model for inorganic arsenic and its mono- and di-methylated metabolites.
El-Masri HA; Kenyon EM
J Pharmacokinet Pharmacodyn; 2008 Feb; 35(1):31-68. PubMed ID: 17943421
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of thiol-supported arsenate reduction mediated by phosphorolytic-arsenolytic enzymes: II. Enzymatic formation of arsenylated products susceptible for reduction to arsenite by thiols.
Gregus Z; Roos G; Geerlings P; Németi B
Toxicol Sci; 2009 Aug; 110(2):282-92. PubMed ID: 19478237
[TBL] [Abstract][Full Text] [Related]
38. Strain-dependent disposition of inorganic arsenic in the mouse.
Hughes MF; Kenyon EM; Edwards BC; Mitchell CT; Thomas DJ
Toxicology; 1999 Sep; 137(2):95-108. PubMed ID: 10521146
[TBL] [Abstract][Full Text] [Related]
39. Toxicity and metabolism of subcytotoxic inorganic arsenic in human renal proximal tubule epithelial cells (HK-2).
Peraza MA; Carter DE; Gandolfi AJ
Cell Biol Toxicol; 2003 Aug; 19(4):253-64. PubMed ID: 14686617
[TBL] [Abstract][Full Text] [Related]
40. Identification of methylated metabolites of inorganic arsenic by thin-layer chromatography.
Stýblo M; Delnomdedieu M; Hughes MF; Thomas DJ
J Chromatogr B Biomed Appl; 1995 Jun; 668(1):21-9. PubMed ID: 7550978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
